Company intelligence / Profile preview

Root Lab

Chuncheon, Gangwon-do, South Korea

Ownership: Private
Development stage: Other

Overview

Root Lab is a South Korean biotechnology company specializing in the development of plant-derived extracellular vesicles (PEVs), commonly known as plant exosomes. The company leverages its proprietary isolation and purification technology to harness the therapeutic and delivery potential of PEVs for applications in dermatology, regenerative medicine, and drug delivery. Root Lab's pipeline focuses on treating inflammatory skin conditions such as atopic dermatitis and enhancing skin health through bioactive compounds encapsulated within stable plant-based vesicles. By utilizing plant sources, the company aims to provide a scalable, safe, and cost-effective alternative to animal- or human-derived exosome therapies.

Therapeutic areas: DermatologyImmunology
Modalities: Exosome-based therapyBiologicPlant extract
Industry: Biotech

Beyond the preview

Go deeper on Root Lab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Root Lab.

Explore the full profile